APAlicia Pérez-Blanco

Alicia Pérez-Blanco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alicia Pérez-Blanco has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical evidence of the absence of brain perfusion during thoraco-abdominal normothermic regional perfusion in donation after circulatory determination of death

    by Mario Royo-Villanova, Beatriz Domínguez-Gil, José Moya, María Ángeles Ballesteros, Alejandro Ortín, Enrique Montes-Figueroa, Elisabeth Coll, Alicia Pérez-Blanco, Joaquín Zamarro, Borja Suberviola, et al.


  • Open Access

    Five years of a self-sustaining heart transplant program in the Canary Islands

    by Maria del Val Groba-Marco, Vicente Peña-Morant, Francisco González-Vílchez, Mario Galván-Ruiz, Miguel Fernandez-De-Sanmamed, Jose Luis Romero-Lujan, Francisco Portela-Torron, Eduardo Jose Caballero-Dorta, Alicia Pérez-Blanco, Antonio García-Quintana

  • Top Cited Papers
    Open Access

    A scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial

    by Mario Royo-Villanova, Jose Moya Sánchez, Tatiana Moreno-Monsalve, José Contreras, Alejandro Ortín, Héctor Vargas, Clara Manso Murcia, Marta Mateos Llosa, Elisabeth Coll, Alicia Pérez-Blanco, et al.


  • Top Cited Papers
    Open Access

    DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain

    by Alicia Pérez-Blanco, Francisco González-Vilchez, José González-Costello, Mario Royo-Villanova, Eduardo Miñambres, José J. Cuenca, Sergio J. Cánovas, Iris P. Garrido, Gabriel Moreno-González, Fabrizio Sbraga, et al.


  • Open Access

    Assessing Outcomes of Patients Subject to Intensive Care to Facilitate Organ Donation: A Spanish Multicenter Prospective Study

    by Alicia Pérez-Blanco, María Acevedo, María Padilla, Aroa Gómez, Luis Zapata, María Barber, Adolfo Martínez, Verónica Calleja, María C. Rivero, Esperanza Fernández, et al.

    Intensive Care to facilitate Organ Donation (ICOD) consists of the initiation or continuation of intensive care measures in patients with a devastating brain injury (DBI) in whom curative treatment is deemed futile and death by neurological criteria (DNC) is foreseen, to incorporate organ donation into their end-of-life plans. In this study we evaluate the outcomes of patients subject to ICOD and identify radiological and clinical factors associated with progression to DNC. In this first prospective multicenter study we tested by multivariate regression the association of clinical and radiological severity features with progression to DNC. Of the 194 patients, 144 (74.2%) patients fulfilled DNC after a median of 25 h (95% IQR: 17–44) from ICOD onset. Two patients (1%) shifted from ICOD to curative treatment, both were alive at discharge. Factors associated with progression to DNC included: age below 70 years, clinical score consistent with severe brain injury, instability, intracranial hemorrhage, midline shift ≥5 mm and certain types of brain herniation. Overall 151 (77.8%) patients progressed to organ donation. Based on these results, we conclude that ICOD is a beneficial and efficient practice that can contribute to the pool of deceased donors.


  • Open Access

    Uterus Transplantation as a Surgical Innovation

    by Alicia Pérez-Blanco, José-Antonio Seoane, Teresa Aldabo Pallás, Montserrat Nieto-Moro, Rocío Núñez Calonge, Alfonso de la Fuente, Dominique E. Martin

    Uterus transplantation (UTx) research has been introduced in several countries, with trials in Sweden and the United States producing successful outcomes. The growing interest in developing UTx trials in other countries, such as Spain, the Netherlands, Japan, and Australia, raises important questions regarding the ethics of surgical innovation research in the field of UTx. This paper examines the current state of UTx in the context of the surgical innovation paradigm and IDEAL framework and discusses the ethical challenges faced by those considering the introduction of new trials. We argue that UTx remains an experimental procedure at a relatively early stage of the IDEAL framework, especially in the context of de novo trials, where protocols are likely to deviate from those used previously and where researchers are likely to have limited experience of UTx. We conclude that countries considering the introduction of UTx trials should build on the strengths of the reported outcomes to consolidate the evidence base and shed light on the uncertainties of the procedure. Authorities responsible for the ethical governance of UTx trials are advised to draw on the ethical framework used in the oversight of surgical innovation.


  • Open Access

    Family bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol

    by Maria Victoria Martinez-Lopez, Elisabeth Coll, Francisco Cruz-Quintana, Beatriz Dominguez-Gil, Ivar R Hannikainen, Ramón Lara Rosales, Alicia Pérez-Blanco, Maria Nieves Perez-Marfil, Jose Miguel Pérez-Villares, David Uruñuela, et al.

    Introduction There is a discrepancy in the literature as to whether authorising or refusing the recovery of organs for transplantation is of direct benefit to families in their subsequent grieving process. This study aims to explore the impact of the family interview to pose the option of posthumous donation and the decision to authorise or refuse organ recovery on the grieving process of potential donors’ relatives. Methods and analysis A protocol for mixed methods, prospective cohort longitudinal study is proposed. Researchers do not randomly assign participants to groups. Instead, participants are considered to belong to one of three groups based on factors related to their experiences at the hospital. In this regard, families in G1, G2 and G3 would be those who authorised organ donation, declined organ donation or were not asked about organ donation, respectively. Their grieving process is monitored at three points in time: 1 month after the patient’s death, when a semistructured interview focused on the lived experience during the donation process is carried out, 3 months and 9 months after the death. At the second and third time points, relatives’ grieving process is assessed using six psychometric tests: State-Trait Anxiety Inventory, Beck Depression Inventory-II, Inventory of Complicated Grief, The Impact of Event Scale: Revised, Posttraumatic Growth Inventory and Connor-Davidson Resilience Scale. Descriptive statistics (means, SDs and frequencies) are computed for each group and time point. Through a series of regression models, differences between groups in the evolution of bereavement are estimated. Additionally, qualitative analyses of the semistructured interviews are conducted using the ATLAS.ti software. Ethics and dissemination This study involves human participants and was approved by Comité Coordinador de Ética de la Investigación Biomédica de Andalucía (CCEIBA) ID:1052-N-21. The results will be disseminated at congresses and ordinary academic forums. Participants gave informed consent to participate in the study before taking part.


  • Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting

    by Alicia Pérez-Blanco, Marta López-Fraga, John Forsythe, Ana M. Pires Silva, Massimo Cardillo, Petra Novotná, Stefan G. Tullius, Emanuele Cozzi, Tamar Ashkenazi, Francis L. Delmonico, et al.

    Background The access of non-resident patients to the deceased donor waiting list (DDWL) poses different challenges. The European Committee on Organ Transplantation of the Council of Europe (CD-P-TO) has studied this phenomenon in the European setting. Methods A questionnaire was circulated among Council of Europe member states to inquire about the criteria applied for non-residents to access their DDWL. Results Information was compiled from 28 countries. Less than 1% of non-residents received a deceased donor organ. Two countries never allow non-residents to access the DDWL, 4 allow access without restrictions and 22 only under specific conditions. Of those, most give access to non-resident patients already in their jurisdictions who are in a situation of vulnerability (urgent life-threatening conditions). In addition, patients may be given access: i) after assessment by a specific committee (4 countries); ii) within the framework of official cooperation agreements (15 countries); iii) after patients have officially lived in the country for a minimum length of time (8 countries). The ethical and legal implications of these policies are discussed. Conclusions Countries should collect accurate information about residency status of waitlisted patients. Transparent criteria for the access of non-residents to DDWL should be clearly defined at national level.